After administration of the formulation by oral gavage at a total dose of approximately 1.4 mg lutein per rat for 4 weeks, it was effective in alleviating the symptoms of dry eye by reducing oxidative stress and inflammation and restoring mucin levels [56]. The gene discussed is MUC5AC; the disease is Keratoconjunctivitis sicca.